| P50 | author | William E Boden | Q60503412 |
| | Robert A Harrington | Q62914910 |
| | Gregg W Stone | Q90754539 |
| P2093 | author name string | Judith S Hochman | |
| | David O Williams | |
| | T Bruce Ferguson | |
| | David J Maron | |
| P2860 | cites work | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association | Q22241921 |
| | Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility | Q27339134 |
| | Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials | Q28202129 |
| | Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial | Q28210012 |
| | Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials | Q28272636 |
| | Fractional flow reserve versus angiography for guiding percutaneous coronary intervention | Q28306779 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascu | Q30411237 |
| | Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry | Q30841815 |
| | Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data | Q33548587 |
| | Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study | Q33770249 |
| | Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis | Q33791885 |
| | A randomized trial of therapies for type 2 diabetes and coronary artery disease | Q33827504 |
| | Equipoise and the ethics of clinical research | Q34050273 |
| | Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data | Q34118922 |
| | Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial | Q34242531 |
| | Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis | Q34256787 |
| | The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. | Q34320929 |
| | Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis | Q34383960 |
| | Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials | Q34389294 |
| | Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis | Q34452943 |
| | Optimal medical therapy with or without PCI for stable coronary disease | Q34612445 |
| | Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents | Q35783487 |
| | Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial. | Q35999237 |
| | Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. | Q36112385 |
| | Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry | Q36546752 |
| | All-cause mortality benefit of coronary revascularization vs. medical therapy in patients without known coronary artery disease undergoing coronary computed tomographic angiography: results from CONFIRM (COronary CT Angiography EvaluatioN For Clinic | Q36687083 |
| | Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease | Q37041279 |
| | Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction | Q37127474 |
| | Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). | Q37472971 |
| | Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis | Q37502920 |
| | Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. | Q37642525 |
| | A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris | Q38046358 |
| | Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies | Q38112973 |
| | 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideli | Q38235476 |
| | Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia | Q38373158 |
| | Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS a | Q38413785 |
| | Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. | Q38492894 |
| | Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes | Q39199676 |
| | Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease | Q39280410 |
| | Long-term use of ticagrelor in patients with prior myocardial infarction | Q40263764 |
| | Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials | Q40414100 |
| | Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography | Q40585925 |
| | A prospective natural-history study of coronary atherosclerosis | Q41983924 |
| | Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly | Q43240992 |
| | Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia | Q43517610 |
| | Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients | Q43546987 |
| | Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration | Q44618977 |
| | Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve | Q44802468 |
| | Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study. | Q45988763 |
| | Effect of PCI on quality of life in patients with stable coronary disease | Q46429326 |
| | Quantifying the utility of taking pills for cardiovascular prevention | Q46498912 |
| | Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease | Q46820470 |
| | Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients | Q47432715 |
| | Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation | Q47842851 |
| | Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. | Q51182242 |
| | Prediction of mortality by stress echocardiography in 2835 diabetic and 11 305 nondiabetic patients. | Q51278359 |
| | Visual-functional mismatch between coronary angiography and fractional flow reserve. | Q51308840 |
| | Impact of repeat myocardial revascularization on outcome in patients with silent ischemia after previous revascularization. | Q51824558 |
| | Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. | Q51972429 |
| | 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart | Q52956605 |
| | Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. | Q53057713 |
| | Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). | Q53178412 |
| | Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. | Q53248514 |
| | 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu | Q53460540 |
| | Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. | Q53570399 |
| | The impact of revascularization on mortality in patients with nonacute coronary artery disease. | Q54237854 |
| | ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee. | Q54257910 |
| | Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease | Q56767809 |
| | AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update | Q57072671 |
| | 2013 ESC guidelines on the management of stable coronary artery disease | Q57243329 |
| | Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease | Q57787005 |
| | Comparative Outcomes for Patients Who Do and Do Not Undergo Percutaneous Coronary Intervention for Stable Coronary Artery Disease in New York | Q58971548 |
| | Does Percutaneous Coronary Intervention Reduce Mortality in Patients With Stable Chronic Angina | Q59186914 |
| | Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | Q61651378 |
| | Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis | Q61651507 |
| | Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients : study in 1137 patients with 6-year follow-up | Q73049824 |
| | Long-term (10 years) prognostic value of a normal thallium-201 myocardial exercise scintigraphy in patients with coronary artery disease documented by angiography | Q73108355 |
| | The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter S | Q74611586 |
| | Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy | Q80681924 |
| | A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease | Q81931221 |
| | Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists | Q82784651 |
| | ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography | Q83379296 |
| | Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) stud | Q84383774 |
| | Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation | Q84480239 |
| | Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention | Q84761062 |
| | The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk | Q84854642 |
| | Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence | Q87336797 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | revascularization | Q7317735 |
| P304 | page(s) | 81-99 | |
| P577 | publication date | 2015-11-02 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise | |
| P478 | volume | 67 | |